COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME IN CATALONIA

被引：0
|
作者：
Mistry, C. [1 ]
Tilley, L. [2 ]
Comin-Colet, J. [2 ]
Vitale, G. [3 ]
Gaugris, S. [1 ]
Jakouloff, D. [4 ]
机构：
[1] FIECON Ltd, St Albans, England
[2] Hosp Univ Bellvitge, Barcelona, Spain
[3] Amarin Spain & Portugal, Madrid, Spain
[4] Amarin Switzerland GmbH, Zug, Switzerland
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE611
引用
收藏
页码：S175 / S176
页数：2
相关论文
共 50 条
  • [1] BUDGET IMPACT OF ICOSAPENT ETHYL IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME IN CATALONIA
    Mistry, C.
    Tilley, L.
    Comin-Colet, J.
    Vitale, G.
    Gaugris, S.
    Jakouloff, D.
    Lopez, S.
    VALUE IN HEALTH, 2024, 27 (12) : S130 - S130
  • [2] COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN US REDUCE-IT PATIENTS
    Weintraub, William S.
    Bhatt, Deepak
    Zhang, Zugui
    Zhang, Cheng
    Sarahfaye, Dolman
    Boden, William E.
    Steg, Philippe Gabriel
    Miller, Michael
    Brinton, Eliot
    King, Jordan
    Bress, Adam
    Jacobson, Terry
    Tardif, Jean Claude
    Ballantyne, Christie M.
    Kolm, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1914 - 1914
  • [3] Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT
    Weintraub, William S.
    Bhatt, Deepak L.
    Zhang, Zugui
    Dolman, Sarahfaye F.
    Zhang, Cheng
    Boden, William E., II
    Bress, Adam P.
    King, Jordan B.
    Steg, Philippe G.
    Brinton, Eliot A.
    Jacobson, Terry A.
    Tardif, Jean Claude
    Ballantyne, Christie M.
    Kolm, Paul
    CIRCULATION, 2019, 140 (25) : E969 - E970
  • [4] COST-EFFECTIVENESS OF ICOSAPENT ETHYL FOR PREVENTING CARDIOVASCULAR EVENTS
    Dressel, A.
    ATHEROSCLEROSIS, 2023, 379
  • [5] COST-EFFECTIVENESS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Kim, K.
    Calabrese, M.
    Lin, F. J.
    Ojo, O.
    Cavallari, L. H.
    Touchette, D. R.
    VALUE IN HEALTH, 2013, 16 (03) : A284 - A284
  • [6] BENEFITS OF ICOSAPENT ETHYL IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME (ACS): REDUCE-IT ACS
    Steg, Philippe Gabriel
    Bhatt, Deepak L.
    Miller, Michael
    Brinton, Eliot A.
    Jacobson, Terry A.
    Ketchum, Steven
    Jiao, Lixia
    Pineda, Armando Lira
    Doyle, Ralph T.
    Tardif, J. R. Jean Claude
    Ballantyne, Christie M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1113 - 1113
  • [7] COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN THE NETHERLANDS
    Thurston, S. J.
    Webb, K.
    Ong, S.
    Meerding, W. J.
    van Hout, B. A.
    VALUE IN HEALTH, 2009, 12 (07) : A335 - A335
  • [8] COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN SWEDEN
    Thurston, S.
    Webb, C.
    Borgman, B.
    Van Hout, B.
    VALUE IN HEALTH, 2010, 13 (03) : A166 - A167
  • [9] COST-EFFECTIVENESS OF ICOSAPENT ETHYL FOR PATIENTS AT HIGH CARDIOVASCULAR RISK WITH ELEVATED TRIGLYCERIDES IN GREECE
    Stratopoulos, A.
    Kougioumtzoglou, I
    Mortaki, K.
    Rigopoulos, P.
    Jakouloff, D.
    VALUE IN HEALTH, 2023, 26 (12) : S51 - S51
  • [10] Cost-effectiveness of icosapent ethyl for primary and secondary cardiovascular prevention in the UK
    Michaeli, D. T.
    Michaeli, J. C.
    Boch, T.
    Michaeli, T.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2845 - 2845
12345